KR970701561A - 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease) - Google Patents

신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)

Info

Publication number
KR970701561A
KR970701561A KR1019960705232A KR19960705232A KR970701561A KR 970701561 A KR970701561 A KR 970701561A KR 1019960705232 A KR1019960705232 A KR 1019960705232A KR 19960705232 A KR19960705232 A KR 19960705232A KR 970701561 A KR970701561 A KR 970701561A
Authority
KR
South Korea
Prior art keywords
virus
viral disease
antileucoprotease
treating
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019960705232A
Other languages
English (en)
Korean (ko)
Inventor
히로시 기도
마사또 다시로
쇼자부로 세끼도
Original Assignee
아사이 이뻬이
도꾜 다나베 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아사이 이뻬이, 도꾜 다나베 세이야꾸 가부시끼가이샤 filed Critical 아사이 이뻬이
Publication of KR970701561A publication Critical patent/KR970701561A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1019960705232A 1994-03-23 1995-03-20 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease) Withdrawn KR970701561A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP94-52237 1994-03-23
JP5223794 1994-03-23
PCT/JP1995/000513 WO1995025539A1 (en) 1994-03-23 1995-03-20 Novel remedy for respiratory-tract viral disease

Publications (1)

Publication Number Publication Date
KR970701561A true KR970701561A (ko) 1997-04-12

Family

ID=12909121

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960705232A Withdrawn KR970701561A (ko) 1994-03-23 1995-03-20 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)

Country Status (16)

Country Link
US (1) US5900401A (enExample)
EP (1) EP0804930A1 (enExample)
KR (1) KR970701561A (enExample)
CN (1) CN1144488A (enExample)
AU (1) AU689559B2 (enExample)
BG (1) BG100835A (enExample)
BR (1) BR9507165A (enExample)
CA (1) CA2186111A1 (enExample)
CZ (1) CZ265896A3 (enExample)
FI (1) FI963753A0 (enExample)
HU (1) HUT75660A (enExample)
NZ (1) NZ282488A (enExample)
PL (1) PL316444A1 (enExample)
RO (1) RO113431B1 (enExample)
SK (1) SK119896A3 (enExample)
WO (1) WO1995025539A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69810800T2 (de) * 1997-10-07 2003-09-18 Boehringer Ingelheim (Canada) Ltd., Laval Azetidinonderivate zur behandlung von hcmv entzündungen
DE69810651T2 (de) * 1997-10-07 2003-08-21 Boehringer Ingelheim (Canada) Ltd., Laval Azetidinonderivate zur behandlung von hcmv entzündungen
DK1021405T3 (da) * 1997-10-07 2003-02-03 Boehringer Ingelheim Ca Ltd Azetidinonderivater til behandling af HCMV-infektioner
US8679462B2 (en) * 2002-04-11 2014-03-25 Saeed Rezakhany Methods of preventing respiratory infections
AU2021235223A1 (en) * 2020-03-09 2022-09-29 Denis Barritault Composition for the treatment of lesions of the respiratory system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182906A1 (en) * 1984-06-14 1986-06-04 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
WO1986003497A1 (en) * 1984-12-06 1986-06-19 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
IL95223A (en) * 1984-12-06 1992-08-18 Synergen Biolog Inc Dna sequence for production of serine protease inhibitors
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US5334141A (en) * 1992-06-26 1994-08-02 Medrad, Inc. Extravasation detection system and apparatus
EP0666755B1 (en) * 1992-09-09 2003-04-23 Amgen Inc. Inhibition of hiv-infection
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase

Also Published As

Publication number Publication date
US5900401A (en) 1999-05-04
SK119896A3 (en) 1997-04-09
NZ282488A (en) 1999-09-29
WO1995025539A1 (en) 1995-09-28
HUT75660A (en) 1997-05-28
FI963753L (fi) 1996-09-20
RO113431B1 (ro) 1998-07-30
BR9507165A (pt) 1997-09-09
EP0804930A1 (en) 1997-11-05
BG100835A (bg) 1997-06-30
AU1961195A (en) 1995-10-09
AU689559B2 (en) 1998-04-02
PL316444A1 (en) 1997-01-20
CA2186111A1 (en) 1995-09-28
CN1144488A (zh) 1997-03-05
EP0804930A4 (enExample) 1997-11-05
CZ265896A3 (en) 1997-06-11
FI963753A7 (fi) 1996-09-20
HU9602598D0 (en) 1996-11-28
FI963753A0 (fi) 1996-09-20

Similar Documents

Publication Publication Date Title
EP0652011A4 (en) PROPHYLACTIC MEDICINE AND MEDICINAL PRODUCT FOR VIRAL DISEASES OF THE BREATHWAYS.
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
DE60142775D1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
EA200201263A1 (ru) СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
ATE395922T1 (de) Lipid-analoge zur behandlung von viralen infektionen
BR0308444A (pt) Composição de vacina, método de produção de vacina, uso de uma mistura de vlps de hpv 16, hpv 18, hvp 31 e hpv 45, método de prevenção da infecção por hpv ou tratamento de doença relacionada com a infecção por hpv
TW200509961A (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
DE69738535D1 (de) Antivirale mittel aus pflanzenextrakten und deren verwendung zur behandlung viraler infektionen
GEP20104960B (en) USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
WO2001068077A3 (en) Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
SE9602931D0 (sv) New medicinal use
ATE555794T1 (de) Heilmittel gegen hepatitis
Lopes et al. Serine proteases in neutrophil extracellular traps exhibit anti-Respiratory Syncytial Virus activity
BR9913333A (pt) Inibição e tratamento do vìrus da hepatite b e flavivìrus com helioxatina e seus análogos
KR970701561A (ko) 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)
BR9915025A (pt) Reversão de choque sistêmico induzido por vìrus e insuficiência respiratória por bloqueio da via linfotoxina-beta
WO2001097824A3 (de) Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae
PE61699A1 (es) Composicion farmaceutica de lamivudina
MX2021010834A (es) Compuesto y metodo para la prevencion de transmision del virus de influenza.
BRPI0418093A (pt) vìrion de um pneumovìrus, método para produzir vìrions pneumovirais, composição, uso de um vìrion, e, método para a prevenção ou tratamento de uma infecção pneumoviral
ATE222771T1 (de) Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19960921

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19990913

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid